Related Experiment Video
Updated: May 3, 2026

08:26
Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of GoldIII
Published on: August 31, 2018
7.3K
Polynuclear Silver(I)-Quinoxaline Complex: Comprehensive Structural Characterization, Antimycobacterial Properties
Ghada Bouz1,2, Nevena L Stevanović3, Marta Počkaj4
1Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 03 Hradec Králové, Czech Republic.
Pharmaceutics
|February 27, 2026
Summary
A novel silver(I) complex with N-(3'-phenylpropyl)quinoxaline-2-carboxamide (pqx-2ca) shows potent antimycobacterial activity. This compound targets both DNA and essential mycobacterial proteins, offering a dual mechanism for drug development.
Area of Science:
- Coordination Chemistry
- Medicinal Chemistry
- Biophysics
Background:
- Silver(I) complexes with aromatic heterocyclic ligands exhibit significant antimicrobial properties.
- These properties are linked to their ability to interact with biological targets.
- Aromatic heterocyclic ligands are crucial components in developing novel antimicrobial agents.
Purpose of the Study:
- Synthesize and characterize a new polynuclear silver(I) complex with N-(3"-phenylpropyl)quinoxaline-2-carboxamide (pqx-2ca).
- Evaluate the antimycobacterial activity of the synthesized complex.
- Investigate the molecular mechanisms underlying the complex's activity, including DNA and protein interactions.
Main Methods:
- Single-crystal X-ray diffraction for structural confirmation.
- Spectroscopic techniques (NMR, IR, UV-Vis) for characterization.
- Density Functional Theory (DFT) calculations and spectral simulations for solution behavior analysis.
- Antimycobacterial activity assays against various Mycobacterium species.
- Molecular docking studies to assess binding to DNA, bovine serum albumin (BSA), and mycobacterial targets (InhA, MmpL3).
Main Results:
- Successfully synthesized and structurally characterized the polynuclear silver(I) complex [Ag(NO3)(pqx-2ca)]n.
- The complex exhibited significantly enhanced antimycobacterial activity against Mycobacterium tuberculosis H37Ra, M. smegmatis, M. aurum, M. avium, and M. kansasii compared to the free ligand.
- Experimental and docking studies confirmed stable binding to the minor groove of DNA and subdomain III of BSA.
- Docking revealed inhibitory potential against InhA and MmpL3 proteins, with binding affinities comparable to standard inhibitors.
Conclusions:
- The synthesized silver(I) complex [Ag(NO3)(pqx-2ca)]n demonstrates potent antimycobacterial efficacy.
- The complex possesses a dual mechanism of action, targeting both DNA and essential mycobacterial proteins.
- [Ag(NO3)(pqx-2ca)]n is a promising candidate for developing novel silver-based antimycobacterial agents.

